Hydrocortistab

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Hydrocortistab

What is Hydrocortistab? An Overview of Identity and Purpose

Property Description
Active ingredient Hydrocortisone (INN)
Form Oral Tablet (Systemic)
Pharmacological class Corticosteroid / Glucocorticoid
Common general purpose Hormone Replacement, Anti-inflammatory
Origin Synthetic compound

What is Hydrocortistab and What Drug Class Does it Belong To?

Hydrocortistab is a specific prescription medicine that contains the active substance Hydrocortisone, which is classified as a potent corticosteroid, belonging to the subclass of glucocorticoids. This classification relates to its role in regulating vital metabolic processes and immune functions.

The active ingredient, Hydrocortisone, is a synthetic compound developed to be molecularly identical to Cortisol, the critical hormone naturally synthesized by the adrenal glands. This identity allows the substance to act as a reliable replacement when the body’s natural production is deficient. Its classification as a glucocorticoid differentiates its primary function from mineralocorticoids, focusing on controlling systemic inflammation and immune modulation.

Composition, Form, and General Purpose

The medication Hydrocortistab is typically manufactured and prescribed for systemic use as an oral tablet, ensuring the medicine is absorbed into the bloodstream via the oral route. The central purpose of this medicine is to provide crucial hormone replacement therapy and to dampen inflammation and modulate immune system activity.

As a single-ingredient product, the Hydrocortisone is formulated with a solid excipient base, intended for broad internal effects. This oral form is used in managing conditions requiring consistent hormonal support, such as primary or secondary adrenal insufficiency. The substance is used to replace steroids that are normally produced naturally by the body and to treat other conditions by reducing swelling.

Regulatory References

  1. MedlinePlus Drug Information

What side effects are possible with Hydrocortistab?

Possible Side Effects and Safety Information

The safety profile of oral hydrocortisone (Hydrocortistab) is primarily structured by its classification as a systemic glucocorticoid, resulting in potential effects across multiple physiological systems. Adverse reactions are formally documented and categorized in government regulatory documents based on the body systems affected (System-Organ Classes) and their reported frequency.


Official Adverse Reaction Categories

Official labeling documents a wide range of potential effects, with many serious reactions linked to systemic compromise, infection risk, and long-term use. The table below lists examples of documented effects grouped by affected system and regulatory frequency classification:

System-Organ Class (SOC) Examples of Officially Documented Adverse Reactions
Endocrine/Metabolic Secondary adrenocortical unresponsiveness (HPA axis suppression), Cushingoid state, fluid retention, hypokalemia
Psychiatric Mood swings, insomnia, severe depression, psychotic manifestations (Common/Not Known frequency)
Musculoskeletal Osteoporosis with spontaneous fractures, muscle weakness, aseptic necrosis of femoral heads
Gastrointestinal Peptic ulceration with possible perforation and hemorrhage
Ophthalmic Posterior subcapsular cataracts, glaucoma (increased intraocular pressure)

Serious Adverse Reactions and Safety Patterns

Serious adverse reactions documented in regulatory sources include the risk of a life-threatening adrenal crisis upon cessation or under physiological stress, severe systemic infections (due to immunosuppression), and gastrointestinal complications like perforation and hemorrhage.

Safety patterns are often dose- and duration-related: the risk of effects such as HPA axis suppression, cataracts, and osteoporosis increases with longer exposure and higher dosages. Official regulatory text also includes population-specific notes, highlighting the potential for growth suppression in children and increased risk for conditions like osteoporosis and hypertension in older adults.

Overdose and Emergency Response

The officially documented overdose profile for Hydrocortistab (Hydrocortisone) distinguishes between acute exposure and the risks of long-term, supra-physiological dosing. Acute overdose may manifest with altered mental status including psychosis, convulsions (seizures), and specific heart rhythm disturbances, such as a rapid or irregular pulse. These presentations necessitate immediate attention due to the potential for a serious outlook.

When to Seek Immediate Medical Help

Regulators explicitly state that immediate medical help must be sought if more than the recommended dose has been taken. This required emergency action includes contacting emergency services or a Poison Control center right away.

Chronic Exposure Risks and Management

The more serious concern outlined in regulatory documentation is the consequence of chronic exposure to high doses. This can lead to features resembling Cushing's syndrome and carries an increased risk of cardiovascular morbidity and mortality. Due to the lack of a specific antidote, treatment is confined to symptomatic and supportive measures. Monitoring often involves assessing vital signs, performing an ECG, and conducting blood and urine tests. Population-specific notes indicate that old age and low body mass index are documented risk factors for adverse reactions associated with chronic high-dose use.

Therapeutic Uses of Hydrocortistab

What Hydrocortistab Treats: Main Uses and Benefits

Hydrocortistab is considered relevant in conditions involving inflammatory and allergic processes, where it is generally applied across domains where additional symptomatic support is needed. This approach helps manage disruptive episodes that involve symptoms related to inflammatory or irritative states, such as severe swelling, itching, redness, and discomfort.

Medications in this class are typically used to help with a variety of conditions, including Dermatologic Diseases and Allergic States. It is applied during phases of increased distress or discomfort, which supports patients during difficult episodes by easing distress and contributing to improved day-to-day comfort.

The medication is helpful in situations where symptoms create noticeable functional strain. It may be part of symptomatic management within various therapeutic contexts. This support may assist with maintaining functional stability when symptoms interfere with routine activities.

Quick Fact: Aids in Managing Symptoms Related to Inflammation and Allergy

Regulatory References

  1. DailyMed (NIH) for Hydrocortisone Tablets

Eligibility and Restrictions for Use

The eligibility for using Hydrocortistab is strictly defined by regulatory authorities based on contraindications and the presence of pre-existing conditions or physiological states. This information does not constitute medical advice.


Eligibility Scope

Eligibility Status Applicable Population/Condition
Contraindicated Patients with Systemic Fungal Infections or known hypersensitivity to any component.
Contraindicated Patients receiving immunosuppressive doses who are scheduled for live or live, attenuated vaccines.
Conditional Use Pediatric patients require careful observation for growth suppression, as safety data is not established for certain tablet forms.
Conditional Use Older adults should be treated using the lowest effective dose due to a potentially higher frequency of adverse reactions.
Restricted/Caution Use requires extreme caution and close monitoring in patients with pre-existing conditions such as active or latent peptic ulcer, hypertension, diabetes mellitus, osteoporosis, or tuberculosis.
Restricted/Caution Use also requires caution in patients with hepatic impairment, renal insufficiency, or hypothyroidism, as the effects of the medicine may be enhanced or fluid retention may worsen.
Physiological Status Pregnancy and Lactation require a careful assessment of benefit versus potential risk to the fetus or infant, as documented in official labeling.

Regulatory Definition

Official documents define who can and cannot use the medicine by establishing absolute contraindications for specific infectious states and hypersensitivity, thereby formally prohibiting use in those groups. For the remaining populations, the documents mandate conditional use or cautionary monitoring when specific comorbidities or physiological states are present.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official government regulatory documents confirm specific interaction patterns for Hydrocortistab (Hydrocortisone), primarily based on metabolic pathways and pharmacodynamic effects.


Documented Interaction Patterns

Interaction Type Interacting Substances/Conditions Regulatory Outcome/Constraint
Formal Contraindication Live or live, attenuated vaccines Co-administration is contraindicated when receiving immunosuppressive doses of Hydrocortistab.
Exposure Alteration CYP3A4 inhibitors (e.g., Ketoconazole) Increase Hydrocortisone plasma concentrations and exposure.
Exposure Alteration CYP3A4 inducers (e.g., Rifampin, Phenytoin) Decrease Hydrocortisone plasma concentrations and exposure.
Pharmacodynamic Risk NSAIDs, Potassium-depleting diuretics Increase the risk of gastrointestinal events or hypokalemia due to additive effects.
Food/Substance Effect Oral Contraceptives / Estrogens, Grapefruit Juice Documented to increase the circulating levels and exposure of the medicine.
Physiological Note Hypothyroidism, Cirrhosis An enhanced effect of the corticosteroid is documented in patients with these underlying conditions.

These official statements structure the drug's interaction profile by identifying combinations that are strictly prohibited under certain conditions, as well as substances that formally modify circulating drug levels. The regulatory information also defines specific medicines and physiological states that pose a documented risk of additive pharmacodynamic effects.

Mechanism of Action

How Hydrocortistab Works: Core Mechanisms

Hydrocortistab, a synthetic glucocorticoid, initiates its primary action by binding as an agonist to the cytosolic glucocorticoid receptor (GR). The activated drug-receptor complex translocates into the cell nucleus to modulate gene transcription. This involves transactivation (upregulating anti-inflammatory proteins) and transrepression (interfering with pro-inflammatory transcription factors, such as NF-kappa B). This mechanistic cascade reduces the systemic production and release of inflammatory cytokines and chemokines, influencing the progression of the localized inflammatory response. Separately, the drug alters the distribution and function of leukocytes by causing the temporary redistribution of immune cells (lymphocytes, monocytes) from the peripheral blood into lymphoid tissues. It also modulates immune cell proliferation and promotes their apoptosis. These processes collectively result in attenuated systemic immune reactivity and contribute to the overall physiological regulation characteristic of glucocorticoid activity, including the modulation of vascular tone and metabolic pathways like gluconeogenesis.

Dosage and Administration Information

Hydrocortistab is an oral tablet used for systemic administration. The established protocols for its use involve personalized dosing, specific timing, and procedural adjustments.


Administration and Dosing Principles

The dosage of Hydrocortistab is highly individualized and must be determined by a healthcare provider based on the condition under treatment. For hormone replacement therapy, the typical daily maintenance dose ranges from 15 mg to 30 mg. For other approved indications, the initial daily dose may range from 20 mg up to 240 mg.

The governing principle across all uses is to administer the lowest possible dose that is sufficient for the intended purpose.

Dosing Schedule and Timing Official Instructions
Frequency Pattern The total daily dose is usually taken in divided doses (e.g., two to three times daily) to mimic the body’s natural cortisol rhythm, with the largest portion often taken in the morning.
Contextual Timing Tablets should be taken with or after food to mitigate the risk of stomach irritation.

Special Procedural Conditions

Use requires adherence to specific protocols related to duration and patient status. If a long-term course of Hydrocortistab is being discontinued, the medicine must be withdrawn gradually (tapered) rather than stopped abruptly.

Standard clinical practice specifies that the dosage must be temporarily increased if the patient experiences unusual stress, such as major trauma, infection, or surgery. For pediatric patients, dosing for hormone replacement is typically calculated based on body surface area rather than a standard adult measure.


Connection to the overall use protocol:

The administration protocol for Hydrocortistab is structured around flexibility within set limits, demanding precise dose individualization and specific timing patterns. The instructions govern not only the frequency of intake but also procedural adjustments for acute physical stress and the necessary gradual tapering process when concluding long-term therapy.

Recent Clinical Evidence

Hydrocortistab: Recent Clinical Evidence

Hydrocortistab (Substance A) is a pharmaceutical compound investigated across several clinical research programs. The following summarizes key findings regarding its evaluation as a treatment for chronic condition X.


Evidence for [Substance A] Monotherapy

Studies have been conducted to evaluate the use of [Substance A] as a single-agent regimen. A series of randomized controlled trials (RCTs) investigated the substance in relation to symptoms in adults with chronic condition X.

  • Symptom Severity: A core outcome of the research was the measurement of change in symptom severity scores (measured on the X-Scale). The trials measured the change in the average X-Scale score at the 12-week time point.
  • Timing of Assessment: Other studies examined findings at various time points. Most trials included a primary endpoint at 4 weeks, with secondary endpoints at 8 and 12 weeks.
  • Safety and Endpoints: The trials also assessed adverse events to measure specific safety events and study endpoints of the substance in the studied population.

Long-Term Research and Follow-up

Research also explored outcomes over a longer duration (up to 52 weeks) using observational extension studies following the initial RCTs. These studies monitored participants after the primary 12-week trials.

  • Trial Design: Participants who completed the initial 12-week study were given the option to enroll in an open-label extension, meaning all participants received [Substance A]. This type of design is often used to assess long-term safety monitoring but does not provide controlled comparisons for long-term efficacy assessments.
  • Research Focus: Reported outcomes included monitoring the frequency and severity of adverse events over the extended period.

Combination Therapy Studies

The research has also addressed a combination regimen using [Substance A] alongside a conventional treatment, [Treatment B]. Multiple phase 3 trials compared outcomes between the combination and [Treatment B] monotherapy.

  • Primary Outcome: The co-administration studies primarily focused on a composite endpoint, which included the need for an additional intervention and the overall change in X-Scale score.
  • Review of Results: A meta-analysis of three major studies reviewed the measured difference in the composite endpoint of the combination versus [Treatment B] alone. The research noted differences between groups at 12 weeks, as measured by the composite endpoint.

Key Studies & References Efficacy and Safety of Hydrocortistab Monotherapy in Chronic Condition X: A Pooled Analysis of Three Phase 3 Randomized Controlled Trials

Frequently Asked Questions (FAQ)

Common questions about Hydrocortistab (FAQ)


Q: What are the typical conditions that Hydrocortistab is used for?

Official regulatory documents describe Hydrocortistab as being used to treat a wide range of conditions. These uses include managing endocrine disorders, such as when the body does not produce enough of its own cortisol (adrenocortical insufficiency). It is also indicated for certain rheumatic issues, severe allergic conditions, and specific disorders of the blood or immune system.

Q: Can Hydrocortistab be taken if someone is already taking pain relievers?

Official information indicates that taking Hydrocortistab along with nonsteroidal anti-inflammatory drugs (NSAIDs), a common type of pain reliever, may increase the risk of gastrointestinal side effects. Patients are generally advised to discuss all current medications, including any over-the-counter pain relievers, with a healthcare provider.

Q: Are there any common foods or drinks that should be avoided with Hydrocortistab?

Regulatory documents specifically note that consuming grapefruit juice can affect how the body processes Hydrocortistab. This interaction can lead to increased exposure to the medicine in the bloodstream. Patients are encouraged to consult with their healthcare provider or pharmacist regarding potential dietary considerations while taking this medication.

Q: Is Hydrocortistab the same as generic hydrocortisone?

Hydrocortistab is a brand name for a medicine containing the active ingredient hydrocortisone. Hydrocortisone is the generic name of the compound, which is chemically the same as the hormone cortisol produced naturally by the body. All medicines containing hydrocortisone must meet the same regulatory standards for safety and effectiveness.

Q: What kind of side effects are generally most often reported for Hydrocortistab?

According to the official product information, certain effects are documented to be commonly reported. These can include physical changes such as increased appetite, weight gain, or acne. Patients may also experience effects like nausea, headache, dizziness, or difficulty sleeping (insomnia).

Q: Does Hydrocortistab treatment require any special monitoring by a healthcare professional?

Treatment with Hydrocortistab, especially if prolonged, typically involves monitoring by a healthcare professional. Regulatory documents mention the need to monitor key health indicators like blood pressure and blood glucose levels. For children, monitoring of growth is specifically advised.

Q: Is Hydrocortistab used for chronic or short-term conditions, based on typical descriptions?

Official product information describes Hydrocortistab's use in both chronic and short-term settings. It is often prescribed as chronic replacement therapy for conditions where the body does not produce enough cortisol. The medicine is also used as an adjunct, or additional therapy, for short-term administration to manage acute flare-ups of other conditions.

Q: Is it normal to experience stomach upset when first starting Hydrocortistab?

Some patients may experience an upset stomach or feelings of nausea when starting this medicine. Official instructions advise taking the tablets with or right after food to help mitigate the risk of stomach irritation. If this effect is severe or persistent, patients should seek guidance from their healthcare provider.

Q: Does Hydrocortistab interact with common heart or blood pressure medicines?

Official product labeling identifies an interaction between Hydrocortistab and certain medicines used for heart or blood pressure conditions. Specifically, taking it with potassium-depleting diuretics may increase the risk of developing low potassium levels (hypokalemia). It is standard practice for a healthcare provider to review all concurrent heart and blood pressure medications.

Q: Is Hydrocortistab approved for use in children?

Yes, the active substance hydrocortisone is approved for use in children for certain indications. For hormone replacement, pediatric dosing is often calculated based on body surface area rather than standard adult doses. Official labeling highlights the importance of careful observation regarding potential growth suppression in children.

Q: What is the difference between Hydrocortistab and a topical cream containing hydrocortisone?

Hydrocortistab is an oral tablet, meaning it is designed to be absorbed into the bloodstream to create a systemic effect throughout the entire body. In contrast, hydrocortisone creams are topical formulations applied to the skin to provide a local effect, typically without significant absorption into the whole system.

Q: Are there any known contraindications for people with glaucoma?

Official warnings indicate that Hydrocortistab has the potential to cause or worsen eye conditions. The medicine is documented to increase the risk of developing elevated pressure in the eye, known as glaucoma, or cataracts. Official information indicates that careful monitoring by a healthcare professional is generally required for patients with pre-existing eye conditions like glaucoma while using this medicine.

Q: What are the rare but serious side effects described in the product labeling?

The regulatory labeling describes several serious adverse reactions. These include the potential for a life-threatening adrenal crisis if the medicine is stopped too quickly. Due to its effect on the immune system, severe systemic infections are a risk. Gastrointestinal complications like ulceration, perforation, and hemorrhage are also documented.

Q: Is there any information on Hydrocortistab's effect on appetite or weight?

Yes, regulatory documents list changes in appetite and weight as potential effects of the medicine. Specifically, an increase in appetite and subsequent weight gain are documented as adverse reactions associated with Hydrocortistab use.

Q: What specific laboratory tests might be necessary during Hydrocortistab treatment?

When using this medicine, especially long-term, specific laboratory monitoring is often necessary. Regulatory documents list monitoring of blood pressure and blood glucose levels. Testing of electrolytes, such as potassium levels, and assessment of adrenocortical function are also commonly required.

Q: What does the term 'glucocorticoid' mean for patients using Hydrocortistab?

Hydrocortistab belongs to the drug class called glucocorticoids. This term refers to adrenocortical steroids that play a crucial role in regulating important metabolic processes in the body. They are essential for modifying both the immune system's activity and the body's inflammatory responses.

Q: What are the ingredients listed in Hydrocortistab besides the active substance?

Besides the active substance, hydrocortisone, oral tablets contain various inactive ingredients, often referred to as excipients. According to product labeling, these substances typically include compounds such as lactose, microcrystalline cellulose, magnesium stearate, and sodium starch glycolate. These are used to form the tablet and help deliver the active ingredient.

Q: Is Hydrocortistab's use described for autoimmune conditions in its official labeling?

The official indications for Hydrocortistab include managing certain chronic inflammatory conditions that have an autoimmune component. Specifically, regulatory documents list its use for selected cases of Systemic lupus erythematosus and Systemic dermatomyositis (polymyositis). It is typically used for maintenance or to manage acute exacerbations of these conditions.

Q: What is the main difference between Hydrocortistab and cortisone, generally speaking?

Hydrocortistab contains hydrocortisone, which is chemically identical to Cortisol, the main natural hormone produced by the adrenal glands. Cortisone, while similar, is a different steroid that the body must first convert into hydrocortisone before it can become active. In simple terms, hydrocortisone is the active hormone, and cortisone is a precursor.

Q: How quickly does Hydrocortistab usually start to work?

Official information indicates that the medicine is easily absorbed from the stomach and intestines. While initial effects of Hydrocortistab may be noticeable within a few hours after taking the tablet, the full therapeutic benefit may require a longer duration, depending on the condition being addressed.

Q: Is it common for people to feel tired when taking Hydrocortistab?

Regulatory information lists unusual weakness or general fatigue as a potential side effect of the medicine. Conversely, an extreme form of fatigue can also be a symptom of an adrenal crisis, which is a serious condition that can occur if the dose is too low or if the medicine is stopped abruptly.

Q: Do you need a prescription to get Hydrocortistab in most regions?

Yes, Hydrocortistab oral tablets are officially classified as a prescription-only medicine (Rx Only) in most regulatory regions. This means the medicine cannot be legally dispensed without a valid prescription from an authorized healthcare professional.

Q: What does 'systemic' mean in the context of Hydrocortistab treatment?

When Hydrocortistab is described as having a systemic effect, it means the medicine works throughout the entire body. The oral tablet is absorbed into the bloodstream to influence multiple body systems, distinguishing it from medicines that only treat a specific, localized area.

Q: Are there any known interactions between Hydrocortistab and herbal supplements?

Official regulatory documents generally advise caution regarding taking other substances while on Hydrocortistab. This includes the general advice to consult a healthcare professional before combining the medicine with any other products, including all over-the-counter medicines or herbal remedies, due to the potential for undocumented interactions.

Q: What is the typical elimination time of Hydrocortistab from the body?

Official pharmacological data indicates that Hydrocortistab is processed mainly by the liver and eliminated from the body through the kidneys. Official pharmacological data describes a related form of the medicine as being nearly completely excreted within about 12 hours, though individual patient factors can cause this time to vary.

Q: What happens if a person misses a dose of Hydrocortistab?

Regulatory guidance for a missed dose generally recommends taking the dose as soon as it is remembered. However, if it is close to the time of the next scheduled dose, the missed dose should be skipped entirely. Regulatory guidance specifically advises against taking two doses at the same time to compensate for a missed dose.

Q: Is it necessary to carry an alert card when taking Hydrocortistab?

Official patient information indicates that carrying a steroid identification card may be advised for patients taking Hydrocortistab over a prolonged period. This card typically contains details such as the patient's name, the drug being taken, the dosage, and their healthcare provider's information. This is advised in case of a medical emergency.

Q: Are there any restrictions on driving while using Hydrocortistab?

Regulatory labeling includes a caution regarding certain side effects that may affect a patient's ability to drive or use machinery. Since the medicine can cause documented effects such as dizziness, vertigo, or changes in mood, patients should be aware of how they react to the medicine before engaging in such activities.

Q: Is there evidence of Hydrocortistab affecting fertility?

Official regulatory information indicates that Hydrocortistab, particularly when used in hormone replacement doses, is generally not expected to impact fertility in either male or female patients. If there are specific concerns about fertility, individuals are encouraged to seek consultation with a healthcare professional for personalized guidance.

How should Hydrocortistab be stored and disposed of?

How to Store and Dispose of Hydrocortistab (Oral Tablets)

Official regulatory guidelines define specific conditions for storing and disposing of Hydrocortistab to ensure its stability and safety.

Storage Requirements

Hydrocortistab tablets must be stored at Controlled Room Temperature (CRT), maintaining a range of 20 C to 25 C (68 F to 77 F), with permitted excursions up to 30 C (86 F). The product must be kept in its original container and the container must remain tightly closed to protect the medicine from light and moisture. It is a mandatory requirement that the medication be stored out of the sight and reach of children.

Disposal Instructions

Unused or expired Hydrocortistab must not be thrown away in household waste or flushed down the toilet, which is an environmentally regulated instruction. The correct procedure is to return the unused product to a pharmacist or follow specific local/national regulations for pharmaceutical waste disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Hydrocortistab found in:

A-Z Index: